Vima Therapeutics

Cambridge, United States

Vima Therapeutics operates as a biotechnology company.

$40.0M raised

Mar 2026

Series A

Biotechnology Health Care Medical

Top Investors

Canaan PartnersFrazier Life SciencesAtlas VentureAccess Industries

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vima Therapeutics

How much funding has Vima Therapeutics raised?

Vima Therapeutics has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.

Who are Vima Therapeutics's investors?

Vima Therapeutics's investors include Canaan Partners, Frazier Life Sciences, Atlas Venture, Access Industries.

Where is Vima Therapeutics headquartered?

Vima Therapeutics is headquartered in Cambridge, United States.

What does Vima Therapeutics do?

Vima Therapeutics operates as a biotechnology company.

What stage is Vima Therapeutics at?

Vima Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 11, 2026.

MLA

"Vima Therapeutics — Funding & Investors." VCBacked, March 11, 2026, https://www.vcbacked.co/company/vima-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Vima Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/vima-therapeutics

Wikipedia (cite web)

{{cite web |title=Vima Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vima-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 11, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.